High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD

Clinical trial NCT06954025 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06954025
Sponsor: ARQ National Psychotrauma Centre
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Posttraumatic Stress Disorder (PTSD)

Start date: 2025-05-16
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.